Lampert Mark N insider trades
Lampert Mark N has filed 4 Form 4s with the SEC that we hold, for CTIC (Director), Kymera Therapeutics, Inc. (KYMR) (Director), MoonLake Immunotherapeutics (MLTX) (Director, 10% owner) and Olema Pharmaceuticals, Inc. (OLMA) (Director). Across all of them we count 0 purchases worth $0 and 7 sales worth $115.0M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($63.0M). The largest single trade was a sale of 1,932,354 shares of MoonLake Immunotherapeutics worth $32.4M, dated 2026-03-31. The first filing on our record is dated 2022-08-11 and the latest 2026-06-23.
CTIC
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-08-09 | S, sale reported on Form 4 | 3,850,803 | $23.6M | 2022-08-11 |
| 2022-08-09 | S, sale reported on Form 4 | 2,890,723 | $17.7M | 2022-08-11 |
| 2022-08-09 | S, sale reported on Form 4 | 1,289,434 | $7.9M | 2022-08-11 |
| 2022-08-09 | S, sale reported on Form 4 | 469,040 | $2.9M | 2022-08-11 |
Kymera Therapeutics, Inc. (KYMR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MoonLake Immunotherapeutics (MLTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-03-31 | S, sale reported on Form 4 | 1,932,354 | $32.4M | 2026-04-02 |
| 2026-03-31 | S, sale reported on Form 4 | 1,569,116 | $26.3M | 2026-04-02 |
| 2026-03-31 | S, sale reported on Form 4 | 248,530 | $4.2M | 2026-04-02 |
Olema Pharmaceuticals, Inc. (OLMA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1233840) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms